Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PKA gamma Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA528148
Description
Recommended positive controls: 293T, Raji. Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
PRKACG (PRKAC gamma) is a third isoform of the catalytic subunit of cAMP-dependent protein kinase. It was isolated from a human testis cDNA library and was clearly derived from a gene distinct from C-alpha and C-beta and showed tissue-specific expression. Whereas at the amino acid level C-alpha and C-beta showed 93% homology, C-gamma showed only about 80% homology to both C-alpha and C-beta. The PRKACG gene is intronless, contains remnants of a poly(A) tail, is flanked by direct repeats, and is co-linear with the PRKACA gene.
Specifications
| PKA gamma | |
| Polyclonal | |
| Unconjugated | |
| PRKACG | |
| BDPLT19; cAMP-dependent protein kinase catalytic subunit gamma; KAPG; PKA C-gamma; PKACg; PRKACG; protein kinase cAMP-activated catalytic subunit gamma; protein kinase, cAMP-dependent, catalytic, gamma; protein kinase, cAMP-dependent, gamma catalytic subunit; serine(threonine) protein kinase | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 5568 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot | |
| 0.92 mg/mL | |
| PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
| P22612 | |
| PRKACG | |
| Recombinant protein encompassing a sequence within the center region of human PKA C gamma. The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction